MedTech Dive May 11, 2022
Elise Reuter

Medical device companies saw procedures bounce back at the end of the first quarter after a surge of COVID-19 cases at the start of the 2022.

Multiple companies, including GE Healthcare, Intuitive Surgical and Zimmer Biomet, reported a pattern of declining procedure volumes in January — curbed by rising COVID-19 cases — before seeing a recovery in February and March.

Still, medical device firms also flagged several challenges ahead, including shortages of semiconductors and other equipment, rising transportation costs and continued hospital staffing woes

Starting off the earnings season, Johnson & Johnson’s CFO Joseph Wolk said the medtech business experienced a “faster recovery than we anticipated,” with the company noting that diagnostic volumes and surgical volumes were trending up. That...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices, Supply Chain, Technology
Related Articles:
Exo adds FDA-cleared AI tools to handheld ultrasound system
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Is Telepathy Possible? Perhaps, Due To New Technology
FDA Proposes Updated Guidance Concerning Cybersecurity of Medical Devices

Share This Article